Your browser doesn't support javascript.
loading
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis.
Hill, Anita; de Latour, Régis Peffault; Kulasekararaj, Austin G; Griffin, Morag; Brodsky, Robert A; Maciejewski, Jaroslaw P; Marantz, Jing L; Gustovic, Philippe; Schrezenmeier, Hubert.
  • Hill A; Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
  • de Latour RP; Department of Hematology and Bone Marrow Transplant, Hopital Saint-Louis AP-HP, Paris, France.
  • Kulasekararaj AG; Department of Haematology, King's College Hospital, London, UK.
  • Griffin M; Department of Haematology, St. James University Hospital, Leeds, UK.
  • Brodsky RA; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Marantz JL; Alexion, AstraZeneca Rare Disease, Boston, Massachusetts, USA.
  • Gustovic P; Alexion Pharma GmhB, Zürich, Switzerland.
  • Schrezenmeier H; Institute of Transfusion Medicine, University of Ulm, and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany.
Acta Haematol ; 146(1): 1-13, 2023.
Article en En | MEDLINE | ID: mdl-36108594

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística / Anemia Aplásica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística / Anemia Aplásica Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article